









Markets
/
Stocks
/
nasdaq-aemd
/

Aethlon Medical Inc

AEMD

2.230USD

+0.090+4.21%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

169.77KMarket Cap

LossP/E TTM



Aethlon Medical Inc

2.230

+0.090+4.21%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Aethlon Medical Inc

Currency: USD Updated: 2026-02-06

Key Insights

Aethlon Medical Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 121 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 12.38.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Aethlon Medical Inc's Score

Industry at a Glance

Industry Ranking

121 / 205

Overall Ranking

316 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Aethlon Medical Inc Highlights

StrengthsRisks

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Overvalued

The company’s latest PE is -0.01, at a high 3-year percentile range.

Held by The Vanguard

Star Investor The Vanguard holds 0.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.62.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

12.375

Target Price

+478.27%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Aethlon Medical Inc is 6.83, ranking 127 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

6.83

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.67

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.78

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.92

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Aethlon Medical Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Aethlon Medical Inc is 7.19, ranking 116 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.01, which is -67.35% below the recent high of -0.00 and -785.03% above the recent low of -0.13.

Score

Industry at a Glance

Previous score

7.19

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 121/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Aethlon Medical Inc is 6.00, ranking 172 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 12.38, with a high of 15.00 and a low of 9.75.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 2 analysts

Hold

Current Rating

12.375

Target Price

+452.46%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Aethlon Medical Inc

AEMD

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Aethlon Medical Inc is 6.63, ranking 112 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.09 and the support level at 1.73, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.43

Change

0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.069

Sell

RSI(14)

37.353

Neutral

STOCH(KDJ)(9,3,3)

8.734

Oversold

ATR(14)

0.266

High Vlolatility

CCI(14)

-112.017

Sell

Williams %R

88.971

Oversold

TRIX(12,20)

-0.694

Sell

StochRSI(14)

63.674

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

2.268

Sell

MA10

2.485

Sell

MA20

2.611

Sell

MA50

3.002

Sell

MA100

4.473

Sell

MA200

11.704

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Aethlon Medical Inc is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 5.57%, representing a quarter-over-quarter decrease of 90.04%. The largest institutional shareholder is James Simons, holding a total of 4.60K shares, representing 0.47% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Alumni Capital LP

22.56K

Ikarian Capital LLC

15.37K

HRT Financial LP

13.06K

Citadel Advisors LLC

9.51K

Renaissance Technologies LLC

Star Investors

4.60K

Two Sigma Investments, LP

3.50K

Scientech Research LLC

2.60K

Intracoastal Capital, L.L.C.

2.10K

Rossetti (Angela)

621.00

-74.20%

Broenniman (Edward G)

222.00

-28.62%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Aethlon Medical Inc is 1.50, ranking 188 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.62. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.